newsfilter
← Latest News
GlobeNewswire·

Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates

WALTHAM, Mass., March 28, 2025 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced financial results for the